Goldman Sachs
ELOS

Goldman Sachs’s Syneron Medical Ltd ELOS Stock Holding History

Goldman Sachs’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-30,000
Closed -$215K – 7535
2015
Q3 		$215K Hold
30,000
– – ﹤0.01% 5953
2015
Q2 		$319K Buy
+30,000
New +$351K ﹤0.01% 5677

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
AIM
Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

Goldman Sachs's ELOS Position: Q3 2017 in Review

Goldman Sachs sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 85,807 shares — an estimated $940K sold.

Goldman Sachs first reported a position in ELOS in Q2 2013 and held it in 11 quarters. The position peaked at $940K in Q2 2017. 4 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

  • Goldman Sachs reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
  • Goldman Sachs sold 85,807 Syneron Medical Ltd shares in Q3 2017, an estimated $940K.
  • Goldman Sachs first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 11 quarters.
  • Goldman Sachs's Syneron Medical Ltd position peaked at $940K in Q2 2017.
  • 4 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on Goldman Sachs's 13F filing for Q3 2017, filed 14 Nov 2017.